| (USD) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -3.44M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PCSA returned -61.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -27.8% |
| 1 year | -61.8% |
| 5 years | -99.9% |
| 10 years | -100.0% |
| All-time high | $61,250.00 (Mar 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PCSA would be worth today ›No. Processa Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Processa Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol PCSA.
Processa Pharmaceuticals, Inc. is part of the Healthcare sector.
Processa Pharmaceuticals, Inc. has a market cap of 5.81M USD, based on the latest quote.
